Search Ontology:
ChEBI
1-hexadecanoyl-2-[(5S,6E,8Z,11Z,14Z)-5-hydroxyicosatetraenoyl]-sn-glycero-3-phosphocholine
- Term ID
- CHEBI:131655
- Synonyms
-
- (2R)-3-(hexadecanoyloxy)-2-{[(5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate
- 1-hexadecanoyl-2-(5S-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine
- 1-palmitoyl-2-[(5S,6E,8Z,11Z,14Z)-5-hydroxyicosatetraenoyl]-sn-glycero-3-phosphocholine
- 16:0/5-HETE-PC
- PC(16:0/20:4(6E,8Z,11Z,14Z)(5OH[S]))
- Definition
- A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and 2 are specified as hexadecanoyl and (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl respectively.
- References
-
- LIPID_MAPS_instance:LMGP20010003
- PMID:27471436
- Reaxys:30084826
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
- has_role
-
Phenotype
Phenotype resulting from 1-hexadecanoyl-2-[(5S,6E,8Z,11Z,14Z)-5-hydroxyicosatetraenoyl]-sn-glycero-3-phosphocholine
Phenotype where environments contain 1-hexadecanoyl-2-[(5S,6E,8Z,11Z,14Z)-5-hydroxyicosatetraenoyl]-sn-glycero-3-phosphocholine
Phenotype modified by environments containing 1-hexadecanoyl-2-[(5S,6E,8Z,11Z,14Z)-5-hydroxyicosatetraenoyl]-sn-glycero-3-phosphocholine
Human Disease Model